Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2493)
|
Core Tip (1797)
|
Full Article (HTML) (51466)
|
Figures (1-9) (1161)
|
Full Article (PDF)-576K (2465)
|
Peer-Review Report-178K (463)
|
Answering Reviewers-107K (441)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (64607)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms

World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (1891)
|
Core Tip (1601)
|
Full Article (HTML) (9913)
|
Figures (1-10) (549)
|
Tables (1-6) (457)
|
Full Article (PDF)-3685K (953)
|
Peer-Review Report-98K (443)
|
Answering Reviewers-50K (358)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (19366)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (1862)
|
Core Tip (1548)
|
Full Article (HTML) (8258)
|
Figures (1-6) (518)
|
Tables (1-2) (326)
|
Full Article (PDF)-1438K (753)
|
Peer-Review Report-192K (272)
|
Answering Reviewers-63K (283)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (17104)
|
Similar Articles (33)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open